Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

Overuse of Opioids, Barbiturates Boosts Chronic Migraine Risk

Self-treating headaches with these drugs doubles chance of having chronic episodes


Related Encyclopedia
 border=
Autism
Bipolar Disorder
Death and Grieving
Dementia
More...

Related Healthscout Videos
 border=
Eight Months on Topamax
Preparing for Topamax
Topamax Effectiveness
Meet Sue Bergeson
More...

Related Animations
 border=
Migraine
More...

Related Drug Information
 border=
Adderal XR
Concerta
Effexor XR
Paxil
More...

Related News Articles
 border=
Health Tip: Trying Pregnancy Again
Anxiety, Shyness May Be Long-Lasting Traits
Relax and Improve Your Genes
Women More Likely to Have Dementia
More...

THURSDAY, April 17 (HealthDay News) -- Taking barbiturates and opioids such as codeine and oxycodone too often for migraines could double the chances of having chronic migraines a year later, new research says.

The study, expected to be presented Thursday at the American Academy of Neurology annual meeting in Chicago, found no increased risk for chronic migraine among people using other common treatments such as triptans or nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, ibuprofen and naproxen.

Text Continues Below



Having migraines on 15 or more days a month is considered a chronic condition.

Those studied had been diagnosed in 2005 with episodic migraines (fewer than 15 days of headache per month) and asked about the types of medications they used that year. Those who took medicines containing barbiturates or opioids for only eight days a month in 2005 were twice as likely to develop chronic migraine a year later as those who didn't take such drugs.

"People who use drugs that contain barbiturates and opioids, if only for a total of seven to eight days a month, appear to significantly increase their risk of migraine progression," study author Marcelo Bigal, of Albert Einstein College of Medicine in New York City, said in a prepared statement. "Strict limits for these types of drugs should be enforced among people with migraine as a way of preventing their migraines from becoming more frequent and more painful."

More information

The U.S. National Library of Medicine has more about migraines.



-- Kevin McKeever

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 4/17/2008

Related Links
 border=
From Healthscout's partner site on migraine, MyMigraineConnection.com
FAQ: Answers to the top 75 migraine and headache questions
DRUGS: Common drugs used to treat migraines
TREATMENT: Lifestyle changes can make migraines more bearable





New Features

New ADHD Site!

SOURCE: American Academy of Neurology, news release, April 17, 2008


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.